Literature DB >> 12091403

Associations of human crystalline lens retrodots and waterclefts with visual impairment: an observational study.

N Andrew Frost1, John M Sparrow, Laurence Moore.   

Abstract

PURPOSE: To investigate the relationships between visual acuity, contrast sensitivity, and 11 clinicopathologic classes of opacity in the human crystalline lens.
METHODS: The Somerset and Avon Eye Study is an observational population study of age-related sight-threatening eye disease, based in Bristol, UK. After excluding eyes with other visually relevant disease, data from 902 individuals aged 55 years or older were analyzed. The associations of lens features (posterior subcapsular cataract, nuclear color, nuclear white scatter, cortical spokes, anterior subcapsular cataract, vacuoles, waterclefts, coronary flakes, focal dots, retrodots, fiber folds), with refracted log minimum angle of resolution (MAR) distance acuity and Pelli-Robson contrast sensitivity, were investigated. Multivariable linear regression models using data from both eyes and taking account of the intraclass correlation between eyes were used for analysis, with the lens features and age included as potential explanatory variables.
RESULTS: As anticipated from earlier studies, posterior subcapsular, nuclear, and cortical cataracts were associated with visual impairment. In addition, retrodots were strongly and independently associated in the multivariable models with both impaired visual acuity (P < 0.001) and contrast sensitivity (P < 0.001). Waterclefts were strongly associated with impaired visual acuity (P < 0.001).
CONCLUSIONS: Retrodots and waterclefts are associated with visual impairment. A causal relationship between these lens features and retinal image degradation is plausible.

Entities:  

Mesh:

Year:  2002        PMID: 12091403

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Retrodots in the lens in the Beaver Dam Eye Study cohort.

Authors:  Barbara E K Klein; Stacy M Meuer; Kristine E Lee; Ronald Klein
Journal:  Ophthalmology       Date:  2010-06-08       Impact factor: 12.079

2.  Lens retrodots and vacuoles and their associations with the prevalence and incidence of age-related cataract.

Authors:  A G Tan; P Mitchell; E Rochtchina; T Hong; R G Cumming; J J Wang
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

Review 3.  The lens as a model for fibrotic disease.

Authors:  J A Eldred; L J Dawes; I M Wormstone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

4.  Analyzing Effect of Waterclefts on Visual Functions Via Optical Simulations.

Authors:  Yusuke Seki; Takushi Kawamorita; Naoki Yamamoto; Takashi Tanigawa; Norihiro Mita; Natsuko Hatsusaka; Eri Kubo; Hiroshi Sasaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

5.  Volumetric macro- and micro-scale assessment of crystalline lens opacities in cataract patients using long-depth-range swept source optical coherence tomography.

Authors:  Ireneusz Grulkowski; Silvestre Manzanera; Lukasz Cwiklinski; Juan Mompeán; Alberto de Castro; Jose Maria Marin; Pablo Artal
Journal:  Biomed Opt Express       Date:  2018-07-24       Impact factor: 3.732

6.  Intralenticular changes in eyes with mature senile cataract on modified posterior segment optical coherence tomography.

Authors:  Amar Pujari; Harathy Selvan; Jayanand Urkude; Rashmi Singh; Ritika Mukhija; Saumya Yadav; Tarjani Makwana; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

7.  Association among pterygium, cataracts, and cumulative ocular ultraviolet exposure: A cross-sectional study in Han people in China and Taiwan.

Authors:  Natsuko Hatsusaka; Naoki Yamamoto; Hisanori Miyashita; Eri Shibuya; Norihiro Mita; Mai Yamazaki; Teppei Shibata; Hidetoshi Ishida; Yuki Ukai; Eri Kubo; Hong-Ming Cheng; Hiroshi Sasaki
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.